U.S. Clinical Nutrition Market Size & Forecast 2025–2034

U.S. Clinical Nutrition Market Size - By Product, By Consumer, By Application, By Dosage Form, By Distribution Channel - Forecast, 2025 - 2034

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definition

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Data mining sources

1.3.1&nbsp;&nbsp;&nbsp; Global

1.3.2&nbsp;&nbsp;&nbsp; Regional/Country

1.4&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.4.1&nbsp;&nbsp;&nbsp; Base year calculation

1.4.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.6&nbsp;&nbsp;&nbsp; Forecast model

1.7&nbsp;&nbsp;&nbsp; Research assumptions and limitations

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 360&deg; synopsis

2.2&nbsp;&nbsp;&nbsp; CXO perspectives: Strategic imperatives

2.2.1&nbsp;&nbsp;&nbsp; Key decision points for industry executives

2.2.2&nbsp;&nbsp;&nbsp; Critical success factors for market players

2.3&nbsp;&nbsp;&nbsp; Future outlook and strategic recommendations

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Rising prevalence of chronic diseases

3.2.1.2&nbsp;&nbsp;&nbsp; High incidence of malnutrition

3.2.1.3&nbsp;&nbsp;&nbsp; Advancements in nutritional science

3.2.1.4&nbsp;&nbsp;&nbsp; Shift toward home healthcare

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; High cost of advanced formulations

3.2.2.2&nbsp;&nbsp;&nbsp; Limited reimbursement policies

3.2.3&nbsp;&nbsp;&nbsp; Market opportunities

3.2.3.1&nbsp;&nbsp;&nbsp; Growing shift towards personalized nutrition solutions

3.2.3.2&nbsp;&nbsp;&nbsp; Demand for plant-based and allergen-free products

3.2.3.3&nbsp;&nbsp;&nbsp; Technological integration

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Technology landscape

3.4.1&nbsp;&nbsp;&nbsp; Current technological trends

3.4.2&nbsp;&nbsp;&nbsp; Emerging technologies

3.5&nbsp;&nbsp;&nbsp; Supply chain analysis for clinical nutrition

3.6&nbsp;&nbsp;&nbsp; Dietary supplements usage scenario in U.S.

3.7&nbsp;&nbsp;&nbsp; Pipeline analysis

3.8&nbsp;&nbsp;&nbsp; Regulatory landscape

3.9&nbsp;&nbsp;&nbsp; Future market trends

3.10&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.11&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Key developments

4.5.1&nbsp;&nbsp;&nbsp; Merger and acquisition

4.5.2&nbsp;&nbsp;&nbsp; Partnership and collaboration

4.5.3&nbsp;&nbsp;&nbsp; New product launches

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Infant nutrition

5.2.1&nbsp;&nbsp;&nbsp; Milk-based

5.2.2&nbsp;&nbsp;&nbsp; Soy-based

5.2.3&nbsp;&nbsp;&nbsp; Organic formula

5.2.4&nbsp;&nbsp;&nbsp; Other infant nutrition

5.3&nbsp;&nbsp;&nbsp; Enteral nutrition

5.3.1&nbsp;&nbsp;&nbsp; Standard composition

5.3.2&nbsp;&nbsp;&nbsp; Disease specific composition

5.3.3&nbsp;&nbsp;&nbsp; Elemental formulas

5.3.4&nbsp;&nbsp;&nbsp; Other enteral nutrition

5.4&nbsp;&nbsp;&nbsp; Parenteral nutrition

5.4.1&nbsp;&nbsp;&nbsp; Amino acids

5.4.2&nbsp;&nbsp;&nbsp; Fats

5.4.3&nbsp;&nbsp;&nbsp; Carbohydrates

5.4.4&nbsp;&nbsp;&nbsp; Vitamins and minerals

5.4.5&nbsp;&nbsp;&nbsp; Other parenteral nutrition

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Consumer, 2021 - 2034 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Pediatric

6.3&nbsp;&nbsp;&nbsp; Adult

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Malnutrition

7.3&nbsp;&nbsp;&nbsp; Cancer nutrition

7.4&nbsp;&nbsp;&nbsp; Metabolic disorders

7.5&nbsp;&nbsp;&nbsp; Neurological diseases

7.6&nbsp;&nbsp;&nbsp; Gastrointestinal disorder

7.7&nbsp;&nbsp;&nbsp; Other applications

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Dosage Form, 2021 - 2034 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Powder

8.3&nbsp;&nbsp;&nbsp; Liquid

8.4&nbsp;&nbsp;&nbsp; Solid

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Distribution Channel, 2021 - 2034 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; Offline channels

9.2.1&nbsp;&nbsp;&nbsp; Hospital pharmacies

9.2.2&nbsp;&nbsp;&nbsp; Retail pharmacies

9.2.3&nbsp;&nbsp;&nbsp; Other offline channels

9.3&nbsp;&nbsp;&nbsp; Online channels

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles 

10.1&nbsp;&nbsp;&nbsp; Abbott (Abbott Nutrition)

10.2&nbsp;&nbsp;&nbsp; Aculife Healthcare

10.3&nbsp;&nbsp;&nbsp; B Braun

10.4&nbsp;&nbsp;&nbsp; BASF

10.5&nbsp;&nbsp;&nbsp; Baxter

10.6&nbsp;&nbsp;&nbsp; Danone

10.7&nbsp;&nbsp;&nbsp; Fresenius Kabi

10.8&nbsp;&nbsp;&nbsp; Grifols

10.9&nbsp;&nbsp;&nbsp; Hero Nutritionals

10.10&nbsp;&nbsp;&nbsp; Hormel Foods

10.11&nbsp;&nbsp;&nbsp; Mead Johnson (Reckitt Benckiser)

10.12&nbsp;&nbsp;&nbsp; Meiji Holdings

10.13&nbsp;&nbsp;&nbsp; Nestle Health Science

10.14&nbsp;&nbsp;&nbsp; Perrigo

&nbsp;&nbsp;&nbsp;

U.S. Clinical Nutrition Market

Inquiry Before Buying